The effect ofdiarachidonin on the synthesis ofprostaglandin E2 in rabbit kidney medulla slices was examined. The addition of diarachidonin stimulated prostaglandin E2 production in a dose-dependent manner. At three concentrations (10, 50 and 100 #M), increases in prostaglandin E2 formation induced by exogenous diarachidonin were 2-fold greater than those induced by exogenous arachidonic acid. Diacylglycerol or phosphatidic acid from egg lecithin had little or no effect on prostaglandin E2 production. Moreover, EGTA failed to inhibit diarachidonin-stimulated prostaglandin E2 formation, indicating that the stimulatory effect of diarachidonin is not mediated through the activation of endogenous phospholipase A2 (including phosphatidic acid-specific phospholipase A2). These results are discussed in the light of our former hypothesis that arachidonic acid release from kidney medulla phospholipids might occur through the sequential action of a phospholipase C coupled to diacylglycerol and monoacylglycerol lipases [Fujimoto, Akamatsu, Hattori & Fujita (1984) Biochem. J. 218, 69-74].
INTRODUCTION
The rate-limiting step in the synthesis ofprostaglandins is the mobilization of arachidonic acid from tissue lipid stores (Vogt, 1978; Isakson et al., 1978) . At least three enzymic pathways have been proposed to mediate release of arachidonic acid for prostaglandin synthesis in kidney medulla and other tissues: phosphatidylinositol-specific phospholipase C, phospholipase A2 and triacylglycerol lipase (Walenga et al., 1981; Bell et al., 1979; Tobian & O'Donnell, 1976; Michell, 1975) . Since phosphatidylinositol of mammalian tissues is almost exclusively in the I-stearoyl-2-arachidonyl form, the phosphatidylinositolspecific phospholipase C pathway allows for the specific release of arachidonic acid (Bell et al., 1979) . Recently, we have reported that exogenously applied phospholipase C stimulates medullary generation ofprostaglandin E2 to a level comparable with that obtained with exogenous phospholipase A2 (Fujimoto et al., 1984) . This study has suggested the possibility that phospholipase C-diacylglycerol lipase pathway is important for prostaglandin synthesis in the kidney.
Following formation of diacylglycerol by phospholipase C, arachidonic acid is either released by diacylglycerol and monoacylglycerol lipases, or the diacylglycerol is phosphorylated to phosphatidic acid (Bell et al., 1979; Billah et al., 1979) . Arachidonic acid may then be released from phosphatidic acid by the action of phosphatidic acid-specific phospholipase A2 . While it is clear that activation of phospholipase C yields diacylglycerol, the fate of the arachidonic acid which enters the diacylglycerol pool and the pathway to its liberation in the kidney have remained obscure. The present paper reports about the effect ofdiarachidonin on the biosynthesis of prostaglandin E2 in kidney medulla slices. Our data are discussed in view of the possible role of diacylglycerol and monoacylglycerol lipases in providing arachidonic acid to cyclo-oxygenase in kidney medulla.
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Materials
Diarachidonin was obtained from Nu-Chek Prep, Inc. (Elysian MN, U.S.A.), and diacylglycerol from egg lecithin was obtained from Serdary Research Laboratories, London, Ontario, Canada. Phosphatidic acid from egg lecithin, arachidonic acid and mepacrine (quinacrine) were obtained from Sigma. p-Bromophenacyl bromide and EGTA were purchased from Wako Pure Chemical Industries, Osaka, Japan. All other reagents were analytical grade.
Methods
Tissue. Male rabbits (2-2.5 kg) were used in the present study. The kidneys were removed from anaesthetized (sodium pentobarbital, 30 mg/kg) rabbits and rapidly chilled in ice-cold 0.9% NaCl. Kidney medulla slices were prepared as described elsewhere (Fujimoto & Fujita, 1982) .
Incubation of medulla slices. In all experiments, rabbit kidney medulla slices (0.4 g) were preincubated in 4.0 ml of 0.15 M-KCI/0.02 M-Tris/HCl buffer, pH 7.4, at 4°C for 5 min. After preincubation, the medium was changed to a new solution containing the indicated concentrations of diarachidonin, arachidonic acid, diacylglycerol or phosphatidic acid. Each lipid was firstly dissolved in dimethyl sulphoxide and then diluted 100-fold into the reaction mixture. Dimethyl sulphoxide at 1 % (v/v) had no effect on prostaglandin E2 production in medulla slices. Incubation was continued for another 30 min to measure prostaglandin E2. In experiments utilizing EGTA, slices were preincubated for 30 min at 37°C in the Tris/HCl buffer with or without 2 mM-EGTA. At t = 30 min, slices were washed briefly and transferred to fresh buffer with or without 2 mM-EGTA, and the incubation was continued to t = 60 min to measure (Fujimoto et al., 1983) . Briefly, prostaglandin E2 extracted with ethyl acetate (pH approx. 3) was measured after its base-catalysed conversion to prostaglandin B2 (Jouvenaz et al., 1970 (Bell et al., 1979; Billah et al., 1979) could initiate mobilization of Ca2+ (Tyson et al., 1976; Gerrard et al., 1978) , which in turn could stimulate phospholipase A2 activity (Rittenhouse-Simmons & Deykin, 1978; Lapetina et al., 1980) .
In order to ascertain these possibilities, we examined the effects of diacylglycerol and phosphatidic acid from egg lecithin on the release ofprostaglandin E2 from rabbit kidney medulla slices (Table 1) . In preliminary experiments, the percentage composition of fatty acids of diacylglycerol or phosphatidic acid from egg lecithin was determined by g.l.c. (Yasuda et al., 1980 The stimulatory effect of diarachidonin on prostaglandin E2 synthesis could be achieved by the activation of endogenous diacylglycerol and monoacylglycerol lipases, or through the involvement ofa phosphatidic acid-specific phospholipase A2 activity. Billah et al. (1981) reported that a phospholipase A2 activity specific for phosphatidic acid was dependent on Ca2+ and this activity was completely inhibited by EGTA. Therefore, we determined the effect ofEGTA on diarachidonin-induced prostaglandin E2 release from rabbit kidney medulla slices (Table 2) . EGTA reduced the production of basal prostaglandin E2 by 55 % at a concentration of 2 mm. It has been shown that phospholipase C activation does not depend on cytoplasmic increases of calcium concentration, at variance with phospholipase A2 (Simon et al., 1984; Rittenhouse, 1984) . The inhibition by EGTA of basal prostaglandin E2 formation appears to be mediated via inhibition of a Ca2+-dependent phospholipase A2 that cleaves arachidonic acid from phospholipids, primarily phosphatidylcholine. In the present study, EGTA had no influence on diarachidonin-stimulated prostaglandin E2 formation. Thus it seems likely that the enhancement of prostaglandin E2 formation elicited by diarachidonin can be ascribed to increased availability of free arachidonic acid by diacylglycerol lipase and monoacylglycerol lipase, rather than by way of a phosphatidic acid-specific phospholipase A2, which in turn suggests the presence of diacylglycerol lipase and monoacylglycerol lipase in the kidney. This is reinforced by the fact that the addition of diarachidonin produced a 2-fold greater increase in prostaglandin E2 release than was seen in response to arachidonic acid (Fig. 1) . The failure of EGTA to inhibit diarachidonin-stimulated prostaglandin E2 formation also suggests that diacylglycerol and monoacylglycerol lipases of kidney medulla are independent of Ca2+. This result is in agreement with previous data (Chau & Tai, 1981) which indicated that there was no effect of EDTA or Ca2+ on human platelet diacylglycerol or monoacylglycerol lipase activity. Authi et al. (1985) also demonstrated that diacylglycerol lipase in human platelet intracellular and surface membranes was optimally active in the absence ofcalcium (stimulated by 1 mM-EGTA and partially inhibited by added calcium). In the same study they suggested that the phospholipase C-diacylglycerol lipase pathway might be independent of changes in cell calcium levels.
Mepacrine and p-bromophenacyl bromide have been shown to inhibit the release of arachidonic acid and the generation of arachidonate-oxygenated products from blood platelets (Vallee et al., 1979) . Recently we reported that mepacrine at a concentration of 1.6 mm, and p-bromophenacyl bromide atO. 1 mm, inhibited exogenous phospholipase A2-stimulated prostaglandin E2 production by 48% and 58% respectively (Fujimoto et al., 1984) . In the same study, we suggested that p-bromophenacyl bromide was a direct inhibitor of phospholipase A2 and that mepacrine might work in an indirect way. As shown in Table 3 , diarachidonin-induced prostaglandin E2 release of 2.13 ,ug/g of tissue was reduced by treatment with mepacrine (1.6 mM) to 0.86 ,ug/g of tissue. In Vol. 232 627 contrast, p-bromophenacyl bromide (0.1 mM) failed to inhibit diarachidonin-stimulated prostaglandin E2 formation. Dise et al. (1982) reported that mepacrine interacted directly with membrane phospholipids, primarily phosphatidylethanolamine, to form less-polar derivatives, and that mepacrine-phospholipid interaction could alter membrane architecture and disrupt membrane proteinlipid interactions. It is possible to ascribe the inhibitory effect of mepacrine towards diacylglycerol and monoacylglycerol lipases to a phospholipid-mepacrine interaction. On the other hand, it has been shown that p-bromophenacyl bromide can inhibit phosphatidylinositol-specific phospholipase C from platelets, possibly by interaction with thiol groups Kyger & Franson, 1984) . The lack of effect of pbromophenacyl bromide on diarachidonin-induced prostaglandin E2 release was interpreted as indicating that sulphydryl groups were not essential for the activation of diacylglycerol and monoacylglycerol lipases in kidney medulla. Similar properties have been described for rat plasma and platelet monoacylglycerol lipases (Fielding, 1981) .
The results of this work suggest the presence of diacylglycerol lipase and monoacylglycerol lipase in the kidney and the importance of this pathway in prostaglandin synthesis by the kidney. Also, a study of some properties of these enzymes was performed. However, it does not necessarily support that the diacylglycerol/ monoacylglycerol lipases pathway plays a major role in arachidonic acid release for prostaglandin synthesis in the kidney. Direct deacylation of phospholipids by phospholipase A2 has been recognized as a favourable pathway, since this represents the simplest mode of release of arachidonic acid (Rittenhouse-Simmons et al., 1976; McKean et al., 1981) . In renal medulla, triacylglycerol lipase activity is also a potential mediator of release of arachidonic acid for prostaglandin synthesis (Bojesen, 1969 (Bojesen, , 1974 Bohman & Jensen, 1976; Tobian & O'Donnell, 1976) . The contribution by the diacylglycerol/monoacylglycerol lipases pathway to overall arachidonic acid release for prostaglandin synthesis in the kidney still remains to be determined.
